4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.41
-0.26 (-3.00%)
At close: Nov 20, 2024, 4:00 PM
8.25
-0.16 (-1.90%)
Pre-market: Nov 21, 2024, 7:38 AM EST
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 147 employees as of December 31, 2023. The number of employees increased by 7 or 5.00% compared to the previous year.
Employees
147
Change (1Y)
7
Growth (1Y)
5.00%
Revenue / Employee
$116
Profits / Employee
-$976,054
Market Cap
388.78M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147 | 7 | 5.00% |
Dec 31, 2022 | 140 | 16 | 12.90% |
Dec 31, 2021 | 124 | 41 | 49.40% |
Dec 31, 2020 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Revance Therapeutics | 597 |
Sangamo Therapeutics | 405 |
Verve Therapeutics | 255 |
Prime Medicine | 234 |
Akebia Therapeutics | 167 |
ProQR Therapeutics | 157 |
KalVista Pharmaceuticals | 150 |
Semler Scientific | 92 |
FDMT News
- 7 days ago - 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewsWire
- 16 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Encourages Investor Participation - Accesswire
- 17 days ago - Shareholders Are Invited To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 18 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out - Accesswire
- 21 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out - Accesswire
- 23 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Take Part - Accesswire
- 24 days ago - Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 26 days ago - Shareholders Are Encouraged To Join An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire